Bilateral Serous Retinal Detachments Following Diode Laser Treatment for Retinopathy of Prematurity
We report a rare retinal complication in a premature infant undergoing diode laser treatment for retinopathy of prematurity (ROP).
Report of a Case.
A male infant (triplet 2) was born at 27 weeks' postconceptional age at a birth weight of 810 g. Retinopathy of prematurity was present when he was screened at 31 weeks' postconceptional age. Threshold ROP was reached at 33 weeks (8-9 cumulative clock hours of stage 3 ROP in zone 2 with plus disease in 4 quadrants bilaterally). Both eyes were treated with an indirect diode laser (810 nm) via a 28-diopter lens anterior to the ridge (500-mW intensity/500-millisecond duration; 1170 burns OD and 940 burns OS). No adverse cardiovascular or other events were noted during or after treatment.
Immediately following treatment, the posterior poles of both eyes became edematous and elevated. These serous retinal detachments resolved within 3 weeks with no recurrence after 18 months of follow-up. A small pigmented spot developed at both maculae as the edema resolved (Figure 1) . The ROP regressed without further treatment.
Triplet 1 (male; 850-g birth weight) reached threshold ROP at 35 weeks (8-9 cumulative clock hours of stage 3 ROP in zone 2 with plus disease in 4 quadrants bilaterally). Both eyes received indirect diode laser treatment (400-mW intensity/400-millisecond duration; 1200 burns OD and 840 burns OS). No retinal problems were noted following treatment. This infant also developed grade 4 intraventricular hemorrhage. Triplet 3 (female; 990-g birth weight) developed ROP bilaterally but did not reach threshold. All 3 infants received supplemental oxygen.
All infants undergoing ROP screening and treatment undergo dilation with a combination of 0.5% cyclopentolate hydrochloride and 0.5% hydrochloride and 2.5% phenylephrine drops (repeated once). When diode laser treatment is indicated, children are sedated with intravenous morphine. 3 Williams and Trese 4 reported a unilateral punched-out macular lesion with pigmentary change in an 11-year-old girl who had been born prematurely but had never received any treatment for ROP.
Comment
Phenylephrine drops are an unlikely cause for these posterior segment changes, given their widespread use in preterm infants and the rarity of these complications. We hypothesize that the diode laser treatment in our case may have caused an inflammatory reaction that led to fluid exudation. Fluid collection at the macula may be responsible for subsequently observed macular pigmentary changes, as suggested by Williams and Trese. 4 However, inflammation following treatment would not explain the retinal changes in children who did not receive treatment 2, 4 ; Different etiological mechanisms may apply in different situations. Individual factors such as very low birth weight, early development and treatment of threshold ROP, and possibly multiple-gestation pregnancy may play a role in the development of subretinal fluid collections in premature infants with ROP. 
Retinal Pigment Epithelium Tumorlike Lesion Arising From an Area Treated With Laser Photocoagulation
Focal hyperplasia of the retinal pigment epithelium (RPE) is a benign condition that can occur as a result of numerous ocular injuries, 1,2 including laser photocoagulation of the choroid or retina in various disease conditions.
3 It appears as an irregular, flat accumulation of black pigment under the sensory retina. It is uncommon for RPE hyperplasia to evolve into elevated, tumorlike lesions. To the best of our knowledge, there has been no documentation of such lesions from their first appearance to full development. This case report documents laser photocoagulation to treat choroidal neovascularization (CNV) associated with age-related macular degeneration evolving into RPE hyperplasia and then a tumorlike elevated lesion.
Report of a Case. In 1991, a 62-year-old African American woman was examined for vision loss in her right eye. Her visual acuity with correction was 20/400 OD and 20/40 OS. She had a subfoveal CNV lesion with subretinal fluid, blood, and lipid components (Figure 1) . A fluorescein angiogram showed subfoveal CNV, composed of classic CNV with no occult CNV, that was less than 3.5 disc areas in size. Laser photocoagulation treatment was applied to decrease the risk of additional severe visual acuity loss. 4 Posttreatmentphotographsconfirmed adequateintensitythroughoutthearea of laser treatment, which covered the lesion in its entirety. One month after treatment, the patient's visual acuity with correction was 20/800 OD.
Two months later, flat foci of RPE hyperplasia were noted. Additionally, prominent retinal folds were observed, suggesting traction by the fibrovascular tissue (Figure 2) . A fluorescein angiogram showed no evidence of recurrent CNV. Hypofluorescence of the center of the le-A B Figure 1 . A, A fundus photograph taken at the initial examination shows a subfoveal choroidal neovascular lesion with subretinal fluid, blood, and lipid components. B, A fundus photograph taken immediately after laser photocoagulation shows the laser-treated area not extending over a pseudopod of blood (arrow).
